| Stephen Michael Scott, MD | |
|
43 Jefferson Blvd, Suite 2, Warwick, RI 02888-1027 | |
| (401) 941-2830 | |
| (401) 941-6886 |
| Full Name | Stephen Michael Scott |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 43 Jefferson Blvd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730152505 | NPI | - | NPPES |
| 7000597 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | RI09755 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Warwick, RI | Home health agency |
| Bayada Home Health Care, Inc | Providence, RI | Home health agency |
| Beacon Hospice, An Amedisys Company | East providence, RI | Hospice |
| The Miriam Hospital | Providence, RI | Hospital |
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Women & Infants Hospital Of Rhode Island | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brown Medicine | 0446159776 | 205 |
News Archive
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Its portfolio combines traditional remedies with modern drug therapies and encompasses more than 30 brands and nearly 220 over-the-counter products.
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
Researchers at the UCLA Samueli School of Engineering have created a new type of insulin that could prevent hypoglycemic episodes among people who use the hormone to manage their diabetes.
› Verified 3 days ago
| Entity Name | Brown Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689626764 PECOS PAC ID: 0446159776 Enrollment ID: O20040219000354 |
News Archive
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Its portfolio combines traditional remedies with modern drug therapies and encompasses more than 30 brands and nearly 220 over-the-counter products.
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
Researchers at the UCLA Samueli School of Engineering have created a new type of insulin that could prevent hypoglycemic episodes among people who use the hormone to manage their diabetes.
› Verified 3 days ago
| Entity Name | Atmed Treatment Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558490151 PECOS PAC ID: 4587655543 Enrollment ID: O20040519001300 |
News Archive
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Its portfolio combines traditional remedies with modern drug therapies and encompasses more than 30 brands and nearly 220 over-the-counter products.
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
Researchers at the UCLA Samueli School of Engineering have created a new type of insulin that could prevent hypoglycemic episodes among people who use the hormone to manage their diabetes.
› Verified 3 days ago
| Entity Name | Atmed Primary Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750410361 PECOS PAC ID: 5294789392 Enrollment ID: O20050311000149 |
News Archive
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Its portfolio combines traditional remedies with modern drug therapies and encompasses more than 30 brands and nearly 220 over-the-counter products.
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
Researchers at the UCLA Samueli School of Engineering have created a new type of insulin that could prevent hypoglycemic episodes among people who use the hormone to manage their diabetes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Michael Scott, MD 17 Virginia Ave, Suite 107, Providence, RI 02905-4406 Ph: (401) 443-4992 | Stephen Michael Scott, MD 43 Jefferson Blvd, Suite 2, Warwick, RI 02888-1027 Ph: (401) 941-2830 |
News Archive
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. Its portfolio combines traditional remedies with modern drug therapies and encompasses more than 30 brands and nearly 220 over-the-counter products.
Tobii Technology, the global market leader in eye tracking, announced today its new Tobii TX300™ Eye Tracker. The TX300 is the first higher-frequency eye-tracking hardware that allows research subjects the freedom of head movement, which helps scientists create more realistic testing environments for detailed and efficient research of natural behavior and higher definition samplings at 300 hertz.
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
Researchers at the UCLA Samueli School of Engineering have created a new type of insulin that could prevent hypoglycemic episodes among people who use the hormone to manage their diabetes.
› Verified 3 days ago
Dr. Sterling Leaf Malish, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |